Colgate-Palmolive Company (NYSE:CL) Shares Sold by Mutual of America Capital Management LLC

Mutual of America Capital Management LLC lessened its stake in shares of Colgate-Palmolive Company (NYSE:CL - Free Report) by 4.7% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 120,307 shares of the company's stock after selling 5,913 shares during the period. Mutual of America Capital Management LLC's holdings in Colgate-Palmolive were worth $11,273,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also modified their holdings of CL. Brighton Jones LLC raised its holdings in shares of Colgate-Palmolive by 4.4% during the 4th quarter. Brighton Jones LLC now owns 10,578 shares of the company's stock worth $962,000 after acquiring an additional 450 shares during the period. Bernard Wealth Management Corp. purchased a new position in shares of Colgate-Palmolive during the 4th quarter worth $36,000. Proficio Capital Partners LLC purchased a new stake in Colgate-Palmolive in the 4th quarter valued at about $186,000. Choate Investment Advisors raised its holdings in Colgate-Palmolive by 4.0% in the 4th quarter. Choate Investment Advisors now owns 9,007 shares of the company's stock valued at $819,000 after buying an additional 350 shares during the period. Finally, one8zero8 LLC purchased a new stake in Colgate-Palmolive in the 4th quarter valued at about $300,000. Hedge funds and other institutional investors own 80.41% of the company's stock.

Colgate-Palmolive Stock Performance

Shares of Colgate-Palmolive stock traded down $0.38 during trading hours on Thursday, hitting $87.28. 3,788,095 shares of the company were exchanged, compared to its average volume of 4,860,882. Colgate-Palmolive Company has a 1 year low of $85.32 and a 1 year high of $109.30. The company has a current ratio of 0.85, a quick ratio of 0.54 and a debt-to-equity ratio of 8.96. The business has a 50-day moving average of $90.40 and a 200-day moving average of $90.41. The stock has a market capitalization of $70.73 billion, a price-to-earnings ratio of 24.66, a P/E/G ratio of 4.63 and a beta of 0.37.

Colgate-Palmolive (NYSE:CL - Get Free Report) last released its quarterly earnings data on Friday, April 25th. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.86 by $0.05. The firm had revenue of $4.91 billion during the quarter, compared to analysts' expectations of $4.92 billion. Colgate-Palmolive had a return on equity of 461.04% and a net margin of 14.52%. Colgate-Palmolive's revenue was down 3.0% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.86 earnings per share. As a group, analysts expect that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, August 15th. Shareholders of record on Friday, July 18th will be issued a $0.52 dividend. This represents a $2.08 annualized dividend and a yield of 2.38%. The ex-dividend date is Friday, July 18th. Colgate-Palmolive's dividend payout ratio (DPR) is 58.76%.

Colgate-Palmolive announced that its board has authorized a stock buyback plan on Thursday, March 20th that permits the company to repurchase $5.00 billion in outstanding shares. This repurchase authorization permits the company to reacquire up to 6.8% of its shares through open market purchases. Shares repurchase plans are typically a sign that the company's board believes its shares are undervalued.

Analyst Ratings Changes

CL has been the topic of several research analyst reports. JPMorgan Chase & Co. boosted their price objective on shares of Colgate-Palmolive from $95.00 to $103.00 and gave the company an "overweight" rating in a report on Monday, April 28th. Piper Sandler dropped their target price on Colgate-Palmolive from $108.00 to $107.00 and set an "overweight" rating for the company in a research report on Monday, March 31st. Wells Fargo & Company lifted their target price on Colgate-Palmolive from $83.00 to $88.00 and gave the company an "underweight" rating in a research report on Wednesday, April 2nd. Citigroup lifted their target price on Colgate-Palmolive from $103.00 to $108.00 and gave the company a "buy" rating in a research report on Monday, April 28th. Finally, Barclays lifted their target price on Colgate-Palmolive from $86.00 to $87.00 and gave the company an "equal weight" rating in a research report on Tuesday. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating and eight have assigned a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of "Hold" and an average target price of $101.00.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.